Lipids that increase insulin sensitivity and methods of using the same
US10604473B2 · kind B2 · utility
2Cited by
6References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Apr 28, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.